SciBase has signed an agreement with the German medical device company DermoScan to link Nevisense with its EIS measurement for early detection of malignant melanoma, with DermoScan’s digital dermoscopy system DermoGenius Ultra.

DermoScan is one of Europe’s foremost manufacturers of digital dermoscopy systems. The agreement means that EIS measurements from Nevisense will be integrated as a standard option in DermoGenius Ultra. The result is that both patient data and Nevisense (EIS) measurements can be shared between the two systems. The solution improves both the clinic workflow and the diagnostic process for dermatology clinics.

“The partnership with DermoScan is an opportunity for SciBase for two reasons – it gives us a channel to reach out to a larger audience and it means that we can provide a better, more integrated solution for clinicians. We see the inclusion of Nevisense EIS as a parameter in the DermoGenius system as a sign of the growing interest in Nevisense and our method. We believe that DermoScan’s broad customer network will have a positive effect on the market penetration of Nevisense,” says Simon Grant, CEO of SciBase.

SciBase and DermoScan will conduct joint marketing efforts of the integrated solution. Through DermoScan’s customer base, SciBase will have the possibility to reach additional key target groups and for DermoScan, they will be able to offer a unique integration with Nevisense.

“We are very happy to reach an agreement to cooperate with the team at SciBase. Nevisense is an exciting new technology that complements perfectly our digital dermatoscopy system DermoGenius Ultra. Integrating the products will help save time and improve patient flow for our customers. We are also looking forward to cooperating in the market with joint sales and marketing activities,” says Johann Tillmann, President DermoScan.

Nevisense is a valuable complement to the visual assessment done with dermoscopy and so it is a clear advantage to integrate of Nevisense and the EIS score into DermoGenius Ultra. For the clinics, it will be easier to integrate Nevisense and the EIS score into their workflow. The integration with DermoGenius also makes it possible to link Nevisense to the most common Electronic Health Record systems in Germany.